Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (431-440 of 721) with videos related to

Pageof 73
Sort By:
Clinical Nuclear Medicine|October 26, 2023
PSMA Radioligand Therapy in Prostate Cancer: Where Are We and Where Are We Heading?Ludmila Santiago Almeida, Elba Cristina Sá de Camargo Etchebehere, Irene García Megías, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 28, 2015
PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcomaWolfgang P Fendler, Mona Lehmann, Andrei Todica, et al.
Journal of Clinical Medicine|December 29, 2019
Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 RadioembolizationMichael Köhler, Fabian Harders, Fabian Lohöfer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2020
Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and ExperiencesJohannes Czernin, Stefano Fanti, Philipp T Meyer, et al.
Seminars in Nuclear Medicine|January 4, 2022
Clinical Use of PET/MR in Oncology: An UpdateRobert Seifert, David Kersting, Christoph Rischpler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2021
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal AdenocarcinomaMatthias R Benz, Wesley R Armstrong, Francesco Ceci, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 13, 2022
Quantitative <sup>99m</sup>Tc-DPD-SPECT/CT assessment of cardiac amyloidosisLukas Kessler, Pedro Fragoso Costa, David Kersting, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2009
Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidineFlorian Eckel, Ken Herrmann, Stefan Schmidt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 16, 2014
Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patientsConstantin Lapa, Thomas Linsenmann, Camelia Maria Monoranu, et al.
Nuklearmedizin. Nuclear Medicine|April 27, 2022
Correction: Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear MedicineMatthias Schmidt, Peter Bartenstein, Jan Bucerius, et al.
Pageof 73

Showing results (431-440 of 721) with videos related to

Sort By:
Pageof 73
Clinical Nuclear Medicine|October 26, 2023
PSMA Radioligand Therapy in Prostate Cancer: Where Are We and Where Are We Heading?Ludmila Santiago Almeida, Elba Cristina Sá de Camargo Etchebehere, Irene García Megías, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 28, 2015
PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcomaWolfgang P Fendler, Mona Lehmann, Andrei Todica, et al.
Journal of Clinical Medicine|December 29, 2019
Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 RadioembolizationMichael Köhler, Fabian Harders, Fabian Lohöfer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2020
Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and ExperiencesJohannes Czernin, Stefano Fanti, Philipp T Meyer, et al.
Seminars in Nuclear Medicine|January 4, 2022
Clinical Use of PET/MR in Oncology: An UpdateRobert Seifert, David Kersting, Christoph Rischpler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2021
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal AdenocarcinomaMatthias R Benz, Wesley R Armstrong, Francesco Ceci, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 13, 2022
Quantitative <sup>99m</sup>Tc-DPD-SPECT/CT assessment of cardiac amyloidosisLukas Kessler, Pedro Fragoso Costa, David Kersting, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2009
Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidineFlorian Eckel, Ken Herrmann, Stefan Schmidt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 16, 2014
Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patientsConstantin Lapa, Thomas Linsenmann, Camelia Maria Monoranu, et al.
Nuklearmedizin. Nuclear Medicine|April 27, 2022
Correction: Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear MedicineMatthias Schmidt, Peter Bartenstein, Jan Bucerius, et al.
Pageof 73